These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 35844369)

  • 41. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.
    Bull MJ; Plummer NT
    Integr Med (Encinitas); 2015 Feb; 14(1):25-33. PubMed ID: 26770128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can Probiotics Cure Inflammatory Bowel Diseases?
    Korada SK; Yarla NS; Bishayee A; Aliev G; Aruna Lakshmi K; Arunasree MK; Dananajaya BL; Mishra V
    Curr Pharm Des; 2016; 22(7):904-17. PubMed ID: 26648465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral Anti-Inflammatory and Symbiotic Effects of Fermented Lingonberry Juice-Potential Benefits in IBD.
    Pärnänen P; Räisänen IT; Sorsa T
    Nutrients; 2024 Aug; 16(17):. PubMed ID: 39275212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbial Modulation in Inflammatory Bowel Diseases.
    Yu J; Cheon JH
    Immune Netw; 2022 Dec; 22(6):e44. PubMed ID: 36627937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges.
    Paudel D; Nair DVT; Joseph G; Castro R; Tiwari AK; Singh V
    Gastroenterol Rep (Oxf); 2024; 12():goae033. PubMed ID: 38690290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Lactic Acid Probiotic Bacteria in IBD.
    Vemuri R; Gundamaraju R; Eri R
    Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbial pathogenesis in inflammatory bowel diseases.
    Kumar S; Kumar A
    Microb Pathog; 2022 Feb; 163():105383. PubMed ID: 34974120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.
    Yan F; Polk DB
    Front Immunol; 2020; 11():1428. PubMed ID: 32719681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies.
    Hsu C; Ghannoum M; Cominelli F; Martino LD
    Inflamm Bowel Dis; 2023 Mar; 29(3):470-479. PubMed ID: 35851921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.